Glycomics Market is predicted to reach USD 7.11 billion at a CAGR of 15.80% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Glycomics Market”.

The Glycomics market is estimated to register a CAGR of 15.80% during the forecast period of 2024 to 2032.

MRFR recognizes the following companies as the key players in the global glycomics market— Thermo Fisher Scientific, Inc., Merck KgaA, Agilent Technologies Inc., Bruker, New England Biolabs, Shimadzu Corporation, Waters Corporation, Takara Bio Inc., Asparia Glycomics, and RayBiotech Life, Inc.

Market Highlights

The global glycomics market is accounted to register a CAGR of 15.80% during the forecast period and is estimated to reach USD 7.11 billion by 2032.

The complicated glycomics profiles of diseases like cancer, diabetes, and neurological illnesses drive the requirement for glycomics research and assessment. Additionally, high operational costs are generally associated with glycomic research since it requires specialist knowledge, expensive equipment, and consumables. Glycomics analysis and technologies can be expensive, which could be a hindrance for institutions and researchers with limited funding. Furthermore, glycomics integration with proteomics, metabolomics, and genomes improves the understanding of intricate biological systems and the causes of disease. Opportunities are created for the glycomics market by this aspect. Moreover, commercialization of glycan-based goods, like medicines and diagnostics, is still relatively constrained in comparison to other omics domains, despite scientific achievements in this area. Ventures in glycomics may not receive funding due to market uncertainty, trademark hurdles, and reimbursement issues.

Access Full Report @ https://www.marketresearchfuture.com/reports/glycomics-market-21859

Segment Analysis

The global glycomics market has been segmented based on product, application, and end use.

On the basis of product, the market is segmented into enzymes (glycosidases, neuraminidases, glycosyltransferases, sialyltransferases, and others), kits (glycan labeling kits, glycan purification kits, glycan release kits, and others), reagents (glycoproteins, monosaccharides, oligosaccharides, and others), and instruments (mass spectrometers, HPLC, MALDI-TOF, array systems, and others). The enzymes segment was attributed to holding the largest market share in 2023. The application of enzymes in commercial processes to produce glycan-based goods, including food additives, pharmaceutical excipients, and biofuels, is growing. As more businesses investigate the possibilities of glycans in diverse industries, there will likely be an increase in the need for enzymes in industrial glycomics applications.

Based on application, the global glycomics market has been segmented into drug discovery & development, diagnostics, and others. In 2023, the drug discovery & development segment was anticipated to have the highest market share. Drug research and discovery involve many phases, from target identification to clinical trials, where glycomics is vital. Drug metabolism, pharmacokinetics, and immunogenicity are all related to glycan profiles, which are further characterized by glycomics. Pharmacological prediction of medication efficacy, toxicity, and immunogenic potential is made easier by the evaluation of glycan changes in response to therapy using glycan analysis techniques like mass spectrometry and glycosyl microarrays.

Based on end-use, the global glycomics market has been segmented into academic & research institutes, pharmaceutical & biotechnology companies, biopharmaceutical companies, and CROs. The category for academic & research institutes was predicted to hold the largest market share in 2023. Technological developments in glycomics, such as the creation of innovative analytical methods, glycan analysis platforms, and bioinformatics tools for glycan data analysis, are mostly driven by academic research centers.

Regional Analysis

The global glycomics market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America consists of the US and Canada. The Europe Glycomics market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Glycomics market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The rest of the world's glycomics market comprises the Middle East, Africa, and Latin America.

The largest market share for glycomics was maintained by the North American regional sector. North America's developed healthcare system makes extensive glycomics research and development possible. Leading biopharmaceutical firms involved in glycomics research and medication development may be found in North America, which supports the market's expansion.

Moreover, the European market has been persistently growing over the forecast period. Europe maintains an outstanding academic and research base, with research centers and universities actively involved in glycomics studies that promote cooperation and creativity.

Additionally, Asia Pacific is anticipated to experience the quickest growth over the forecast period. Rising biopharmaceutical industries in nations like China, India, South Korea, and Japan are propelling market expansion through glycomics research, medication development, and biomanufacturing.

Furthermore, the rest of the world's glycomics market is divided into the Middle East, Africa, and Latin America. In Latin America, the Middle East, and Africa, there is an increasing interest in utilizing glycomics technologies in personalized medicine and clinical diagnostics to enhance disease diagnosis, prognosis, and treatment effectiveness.

Key Findings of the Study

• The global glycomics market is expected to reach USD 7.11 billion by 2032, at a CAGR of 15.80% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market due to its growing biotech and healthcare industries, increased R&D spending, and rising uptake of cutting-edge technologies. This makes the area a major growth prospect in the glycomics market.


• 
  Based on product, the enzymes segment was attributed to holding the largest market in 2023.
  


• Thermo Fisher Scientific, Inc., Merck KgaA, Agilent Technologies Inc., Bruker, New England Biolabs, Shimadzu Corporation, Waters Corporation, Takara Bio Inc., Asparia Glycomics, and RayBiotech Life, Inc. are the key market players.